Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China
· Delayed Price · Currency is CNY 6.76
+0.14 (2.11%)
Mar 10, 2026, 12:24 PM CST
SHE:300639 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,155 | 3,772 | 5,990 | 7,361 | 8,595 | 8,846 | Upgrade
|
| Market Cap Growth | 11.28% | -37.03% | -18.63% | -14.35% | -2.84% | 66.50% | Upgrade
|
| Enterprise Value | 3,210 | 3,054 | 5,316 | 6,815 | 7,868 | 7,720 | Upgrade
|
| Last Close Price | 6.62 | 5.93 | 9.24 | 10.84 | 12.52 | 12.65 | Upgrade
|
| PE Ratio | - | - | 42.64 | 4.26 | 10.09 | 24.39 | Upgrade
|
| Forward PE | - | 24.20 | 23.95 | 4.88 | 12.96 | 16.49 | Upgrade
|
| PS Ratio | 6.01 | 4.63 | 5.42 | 1.32 | 3.22 | 6.53 | Upgrade
|
| PB Ratio | 1.11 | 0.93 | 1.18 | 1.41 | 2.47 | 3.49 | Upgrade
|
| P/TBV Ratio | 1.16 | 0.98 | 1.30 | 1.56 | 2.78 | 3.86 | Upgrade
|
| P/FCF Ratio | 46.53 | - | - | 12.81 | - | 365.76 | Upgrade
|
| P/OCF Ratio | 26.70 | 47.88 | 18.74 | 5.62 | 13.61 | 28.42 | Upgrade
|
| EV/Sales Ratio | 4.64 | 3.75 | 4.81 | 1.22 | 2.94 | 5.70 | Upgrade
|
| EV/EBITDA Ratio | - | - | 33.24 | 2.63 | 6.98 | 15.45 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 2.81 | 7.52 | 17.17 | Upgrade
|
| EV/FCF Ratio | 35.95 | - | - | 11.86 | - | 319.20 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.02 | 0.01 | 0.03 | 0.05 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.33 | 0.05 | 0.16 | 0.15 | Upgrade
|
| Debt / FCF Ratio | 1.19 | - | - | 0.24 | - | 3.12 | Upgrade
|
| Net Debt / Equity Ratio | -0.22 | -0.22 | -0.20 | -0.24 | -0.29 | -0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.12 | 1.34 | -6.35 | -0.49 | -0.90 | -2.35 | Upgrade
|
| Net Debt / FCF Ratio | -9.32 | 12.59 | 15.45 | -2.21 | 104.21 | -48.61 | Upgrade
|
| Asset Turnover | 0.15 | 0.16 | 0.18 | 1.02 | 0.75 | 0.65 | Upgrade
|
| Inventory Turnover | 4.94 | 5.33 | 4.05 | 13.59 | 7.11 | 5.17 | Upgrade
|
| Quick Ratio | 4.65 | 4.70 | 5.86 | 3.05 | 3.44 | 6.06 | Upgrade
|
| Current Ratio | 5.07 | 5.04 | 6.26 | 3.23 | 3.77 | 6.48 | Upgrade
|
| Return on Equity (ROE) | -17.78% | -20.78% | 1.33% | 41.41% | 29.45% | 21.22% | Upgrade
|
| Return on Assets (ROA) | -7.26% | -9.79% | -0.06% | 27.61% | 18.44% | 13.53% | Upgrade
|
| Return on Invested Capital (ROIC) | -18.49% | -22.34% | -0.14% | 63.97% | 45.84% | 33.52% | Upgrade
|
| Return on Capital Employed (ROCE) | -14.00% | -19.40% | -0.10% | 45.10% | 29.40% | 17.60% | Upgrade
|
| Earnings Yield | -12.53% | -17.36% | 2.34% | 23.45% | 9.92% | 4.10% | Upgrade
|
| FCF Yield | 2.15% | -1.84% | -1.10% | 7.81% | -0.11% | 0.27% | Upgrade
|
| Dividend Yield | - | - | 0.70% | 2.15% | 1.24% | 0.71% | Upgrade
|
| Payout Ratio | - | - | 114.22% | 6.62% | 8.93% | 12.07% | Upgrade
|
| Buyback Yield / Dilution | -14.83% | -14.27% | 14.71% | 0.02% | -7.39% | -3.55% | Upgrade
|
| Total Shareholder Return | -14.83% | -14.27% | 15.41% | 2.17% | -6.15% | -2.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.